Zhi Tong Cai Jing·2025-08-22 14:35Core Viewpoint - Fosun Pharma (600196)(02196) plans to adopt a restricted share unit scheme for H-shares in 2025, aiming to incentivize employees through equity participation [1] Summary by Relevant Sections Share Grant Details - The company intends to grant a total of 10.6964 million restricted share units to 201 eligible employees upon the adoption of the plan, with the specific grant date to be determined by the board [1] - The eligible employees can purchase the corresponding number of H-shares at a price of RMB 1.00 per unit after the restricted share units vest [1] Limitations and Allocations - Due to the cap set by the Hong Kong Stock Exchange on H-share plans, the maximum number of restricted share units that can be granted under this plan is 13.3705 million, which corresponds to 13.3705 million H-shares [1] - This represents approximately 0.5007% of the company's total shares and about 2.4716% of the total H-shares (excluding treasury shares) [1]